Secondaries announced 3.18.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Esperion Therapeutics
Symbol: ESPR
Price: Last trade $99.60
Trade Date: 3/19
Shares: 1.5 million
Underwriter(s) Credit Suisse, RBC Capital Markets, UBS Securities
Rating=Subscription Needed

Company: Cellectis, Inc.
Symbol: CLLS
Price: Last trade $36.83
Description: Their ordinary shares are listed on the Alternext market of Euronext in Paris under the symbol ‘ALCLS’.
Trade Date: 3/26
Shares: 3.5 million ADSs
Underwriter(s) BofA Merrill Lynch, Jefferies, Piper Jaffray
Co Manager(s) Oppenheimer & Co., Trout Capital
Rating=Subscription Needed

Company: Assembly Biosciences
Symbol: ASMB
Price: Last trade $13.87
Trade Date: 3/19
Shares: 5.4 million
Underwriter(s) Credit Suisse, William Blair
Rating=Subscription Needed

Company: Garrison Capital Inc.
Symbol: GARS
Price: Last trade $15.00
Trade Date: 3/19
Shares: 809,000
Underwriter(s) Robert Baird & Co.
Rating=Subscription Needed

Company: Concert Pharmaceuticals
Symbol: CNCE
Price: Last trade $16.55
Trade Date: 3/19
Shares: 3.02 million
Underwriter(s) Wells Fargo Securities, JMP Securities
Rating=Subscription Needed

Company: Horizon Technology
Symbol: HRZN
Price: Last trade $14.30
Trade Date: 3/19
Shares: 2.38 million
Underwriter(s) Keefe, Bruyette & Woods, Oppenheimer & Co.
Rating=Subscription Needed

Company: Equity One
Symbol: EQY
Price: Last trade $27.35
Trade Date: 3/19
Shares: 3.9 million
Underwriter(s) Citigroup
Rating=Subscription Needed

Company: Tekmira Pharmaceuticals Corp.
Symbol: TKMR
Price: Last trade $19.76
Trade Date: 3/20
Shares: 6 million
Underwriter(s) Leerink Partners, RBC Capital Markets
Rating=Subscription Needed

Company: PDC Energy
Symbol: PDCE
Price: Last trade $53.34
Trade Date: 3/19
Shares: 3.48 million
Underwriter(s) Goldman Sachs, J.P. Morgan
Rating=Subscription Needed